SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (359)5/26/1999 7:43:00 PM
From: LLCF  Read Replies (2) | Respond to of 579
 
<we'd have Lilly fully funding the phase III trials while SIBI just sits back waiting for data and money.>

I guess being a sceptic at heart I assumed SIBI would have to see these two compounds through the clinic... doesn't really make sense I guess... if LLY is paying (you sure?) I suppose they also get to make the call on whether the P2 is "good" enough to continue? CANT BELIEVE THE STOCK CLOSED WHERE IT DID!

DAK